Tag - SPRB

Markets

SVB Leerink cuts Spruce Biosciences to MP; PT to $5 from $35

SVB Leerink downgraded Spruce Biosciences (NASDAQ:SPRB) to “market perform” from “outperform” and slashed its price target to $5 from $35 after reviewing the company’s third quarter business update, speaking with...

November 16, 2021

Markets

SVB Leerink starts Spruce Biosciences at OP; PT $35

SVB Leerink launched coverage of Spruce Biosciences (NASDAQ:SPRB) with an “outperform” rating and $35 price target. The stock closed at $20.30 on Nov. 2 Spruce is a late-stage biotech company developing therapies for...

November 3, 2020

Tag - SPRB

SVB Leerink cuts Spruce Biosciences to MP; PT to $5 from $35

SVB Leerink starts Spruce Biosciences at OP; PT $35

General

More